Trial intelligence / Profile preview

Colloid vs Crystalloid in Breast Surgery

NCT00431743Phase 4Unknown

Sponsor
Rigshospitalet
Start
Apr 2009
Primary completion
Sep 2009
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of Volulyte in hypovolemia (2 arms), sponsored by Rigshospitalet. Primary endpoint: Orthostatic function measured by Finapress. Status: unknown.

02

Drugs

Volulyte
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT00431743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00431743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call